Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required)
Closed Posted
- Opportunity number
- RFA-DA-26-004
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Up to $225,000
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- 501(c)(3) Nonprofits
- Special District Governments
- County Governments
- Non-501(c)(3) Nonprofits
- Small Businesses
- City/Township Governments
- Independent School Districts
- Tribal Organizations (Not Federally Recognized)
- Higher Education Inst. (Public)
- State Governments
- Public or Indian Housing Auth.
- Higher Education Inst. (Private)
- Tribal Governments (Federally Recognized)
- Other
- For Profit Organizations
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
This Federal Grant Opportunity (RFA-DA-26-004) from the Department of Health and Human Services' National Institutes of Health is seeking applicants to conduct research examining systemic and structural barriers and facilitators to improving the HIV pre-exposure prophylaxis (PrEP) care continuum for people who use substances. The funded R34 clinical trials will develop, implement, and evaluate strategies to address the suboptimal PrEP awareness, uptake, and adherence in this population. Eligible applicants include a wide range of organizations such as nonprofits, government entities, tribal organizations, and small businesses. The research will specifically focus on identifying and addressing structural factors impacting the PrEP care continuum for substance users.
The funding for this opportunity comes from three NIH grant programs: Drug Use and Addiction Research (93.279), Trans-NIH Research Support (93.310), and NIH Office of Research on Women's Health (93.313). While specific award amounts and project durations are not provided, typical NIH grant funding ranges from $100,000 to over $1 million, with projects spanning 2-5 years. The research is expected to be conducted at the applicants' facilities across the United States.
Synopsis
Pre-exposure prophylaxis, also known as PrEP, is a safe, highly effective medication for preventing transmission of HIV from sex or injection drug use. Despite PrEPs high efficacy and its availability for over a decade, the awareness, uptake, and adherence of PrEP, especially among people who use substances remain suboptimal. The goal of this concept is to support research to examine and address systemic and structural factors that impede or facilitate the PrEP awareness, uptake, and adherence, among people who use substances. Projects will develop, implement, and evaluate effective strategies that meet the needs of people who use substances to improve the PrEP care continuum.
Files
| File | Type | Posted |
|---|---|---|
| RFA-DA-26-004-Full-Announcement.html | HTML file |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity